• Oteseconazole (VT-1161): Advanced Antifungal Assay Strategie

  2026-05-14

  Oteseconazole (VT-1161) delivers potent, selective inhibition of Candida growth and stands out for its low risk of drug-drug interactions, enabling robust antifungal workflows. This article guides researchers in experimental design, troubleshooting, and maximizing data quality using Oteseconazole from APExBIO.

• Evaluating Low-Cost Microfluidic Mixers for LNP-mRNA Product

  2026-05-14

  This study systematically assesses low-cost microfluidic mixers and manual pipette mixing for producing lipid nanoparticles (LNPs) encapsulating mRNA, comparing physical properties and expression outcomes. The findings validate the suitability of budget-friendly microfluidic devices for bench-scale and high-throughput LNP-mRNA research, supporting broader accessibility and reproducibility in gene delivery studies.

• Dynasore: Applied Protocols for Dynamin GTPase Inhibition

  2026-05-13

  Dynasore empowers precise and reversible modulation of dynamin-dependent endocytosis, making it a gold-standard tool for dissecting vesicle trafficking and pathogen entry mechanisms. This article unpacks workflow optimizations, experimental troubleshooting, and evidence-driven guidance for leveraging Dynasore in cellular and infection models.

• Cisplatin (SKU A8321): Reliable Solutions for Lab Assays

  2026-05-13

  Navigate common pitfalls in cell viability and apoptosis workflows with evidence-driven insights on Cisplatin (SKU A8321). This scenario-based guide equips biomedical researchers and lab technicians with validated best practices and protocol parameters to improve reproducibility and interpretability in cancer research studies.

• UBR1/UBR2: Central Mammalian ER Stress Sensors and PQC Regul

  2026-05-12

  This study uncovers the pivotal roles of mammalian E3 ubiquitin ligases UBR1 and UBR2 as ER stress sensors and modulators of protein quality control (PQC). The findings reveal that these N-recognins stabilize under ER stress, helping cells adapt and survive, while their loss increases susceptibility to ER stress-induced apoptosis.

• Toremifene in Breast Cancer: Two Decades of Clinical Evidenc

  2026-05-12

  This review synthesizes 20 years of clinical data on toremifene, a selective estrogen receptor modulator (SERM), evaluating its efficacy and safety in hormone receptor-positive breast cancer. The study provides nuanced guidance on its use relative to aromatase inhibitors and highlights the importance of biomarker-driven, personalized therapy.

• Dorsomorphin (Compound C): Precision Tools for AMPK Pathway

  2026-05-11

  Dorsomorphin (Compound C) empowers researchers to dissect AMPK and BMP signaling with unmatched selectivity, fueling breakthroughs in metabolic, autophagy, and differentiation assays. This guide distills best practices for experimental setup, protocol optimization, and troubleshooting—bridging foundational insights with real-world research needs.

• Chlorambucil: Optimizing DNA Crosslinking Workflows in Cance

  2026-05-11

  Chlorambucil, a nitrogen mustard alkylating agent, enables precise DNA crosslinking strategies for apoptosis induction and cytotoxicity profiling in cancer models. This guide provides actionable, evidence-backed workflows and troubleshooting tips to maximize reproducibility and assay sensitivity with APExBIO’s high-purity Chlorambucil.

• Flumequine: DNA Topoisomerase II Inhibitor for Precision Res

  2026-05-10

  Flumequine stands out as a robust DNA topoisomerase II inhibitor, enabling precise control in DNA replication, cancer, and antibiotic resistance research. This article delivers actionable workflows, troubleshooting insights, and practical guidance for maximizing Flumequine’s utility, all grounded in the latest in vitro methodologies and benchmarked by advanced drug response metrics.

• STING agonist-1: Optimizing B Cell Activation Assays in Immu

  2026-05-09

  STING agonist-1 enables robust activation of the STING pathway, directly empowering immunology and cancer researchers to model B cell-driven tertiary lymphoid structures. This high-purity, DMSO-soluble immunology research reagent from APExBIO offers reproducible performance and unique mechanistic clarity for both basic and translational workflows.

• Oteseconazole (VT-1161): Redefining Candida Research Strateg

  2026-05-08

  Explore how Oteseconazole (VT-1161) is reshaping antifungal translational research with its mechanistic selectivity, robust activity against fluconazole-resistant Candida, and low risk of drug-drug interactions. This thought-leadership article bridges detailed mechanistic insight with actionable guidance for experimentalists, offering evidence-driven recommendations and protocol parameters for integrating Oteseconazole into advanced antifungal research workflows.

• Optimizing Tumor Imaging and Assays with Cy5.5 NHS Ester (A8

  2026-05-08

  This article provides a scenario-driven, evidence-based guide for biomedical researchers using Cy5.5 NHS ester (non-sulfonated) (SKU A8103). Through practical lab challenges, it demonstrates how this near-infrared fluorescent dye delivers reproducibility and sensitivity for protein conjugation, in vivo fluorescence imaging, and tumor microbiome research, supported by quantitative data and recent literature.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-05-07

  This study presents a streamlined 3D protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids, offering a robust in vitro model for pharmacokinetic research. The findings address limitations of traditional models and enable more accurate assessment of intestinal drug metabolism relevant to human physiology.

• Reliable Apoptosis Research with Annexin V-Cy5/DAPI Apoptosi

  2026-05-07

  This authoritative guide addresses real-world laboratory challenges in programmed cell death detection by leveraging the Annexin V-Cy5/DAPI Apoptosis Kit (SKU K2255). It explores workflow optimization, data reproducibility, and vendor reliability, providing scenario-driven insights for biomedical researchers and lab technicians.

• Staurosporine: Broad-Spectrum Kinase Inhibitor for Cancer Re

  2026-05-06

  Staurosporine is a potent, broad-spectrum serine/threonine protein kinase inhibitor used extensively in cancer research. It enables precise modulation of kinase pathways and reliable induction of apoptosis in cancer cell lines. APExBIO’s Staurosporine (A8192) is validated for reproducibility and versatility in both mechanistic and translational studies.

14717 records 1/982 page Next 12345 下5页 Last page